Literature DB >> 9514604

Effects of Hange-shashin-to on cholera toxin-induced fluid secretion in the small intestine of rats.

Y Kase1, K Saitoh, M Yuzurihara, A Ishige, Y Komatsu.   

Abstract

The effects of Hange-shashin-to (TJ-14) on cholera toxin-induced intestinal fluid secretion were studied to elucidate the mechanism by which this kampo medicine manifests antidiarrheal effects. TJ-14 suppressed the intestinal fluid secretion induced by cholera toxin (1 microg/rat) in a dose-dependent manner at doses between 125 and 1000 mg/kg. It also inhibited the luminal prostaglandin E2 (PGE2) level. On the other hand, serotonin (5-HT) release was not affected by TJ-14. Subcutaneous injection of indomethacin at 10 mg/kg or ondansetron at 100 microg/kg significantly suppressed intestinal secretion. The luminal PGE2 level was also inhibited by indomethacin (10 mg/kg, s.c.). TJ-14, even at 10(-4) g/ml, had little effect on the phasic contraction of isolated guinea pig ileum induced by 5-HT (2 x 10(-6) g/ml), while ondansetron suppressed the phasic contraction caused by 5-HT. These results indicate that TJ-14 is useful in suppressing cholera toxin-stimulated intestinal fluid secretion, and that this effect is partially due to its suppressive action on the PGE2 level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514604     DOI: 10.1248/bpb.21.117

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells.

Authors:  Yuka Hiroshima; Mika Bando; Yuji Inagaki; Reiko Kido; Masatoshi Kataoka; Toshihiko Nagata; Jun-Ichi Kido
Journal:  Odontology       Date:  2015-02-04       Impact factor: 2.634

2.  The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).

Authors:  Kazuhiro Nishikawa; Toru Aoyama; Mari S Oba; Takaki Yoshikawa; Chu Matsuda; Yoshinori Munemoto; Nobuhiro Takiguchi; Kazuaki Tanabe; Naoki Nagata; Motohiro Imano; Mitsuru Oshiro; Ryoji Fukushima; Masato Kataoka; Satoshi Morita; Akira Tsuburaya; Hideyuki Mishima; Toru Kono; Junichi Sakamoto
Journal:  J Cancer       Date:  2018-04-19       Impact factor: 4.207

Review 3.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

4.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.

Authors:  Toru Aoyama; Kazuhiro Nishikawa; Nobuhiro Takiguchi; Kazuaki Tanabe; Motohiro Imano; Ryoji Fukushima; Junichi Sakamoto; Mari S Oba; Satoshi Morita; Toru Kono; Akira Tsuburaya
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-21       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.